ReP USP - Resultado da busca

Filtros : "Gut" Removido: "FMRP" Limpar

Filtros

Artigo de periodico-carta/editorial
Susceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1*13 but not with tumour necrosis factor alfa: 308 promoter polymorphism (2002)
Bittencourt, P. L.; Palacios, S. A.; Cançado, E. L. R.; Carrilho, Flair José; Porta, Gilda; Kalil Filho, Jorge Elias; Goldberg, A. C.
Source: Gut. Unidade: FM
Assunto: GASTROENTEROLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITTENCOURT, P. L. et al. Susceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1*13 but not with tumour necrosis factor alfa: 308 promoter polymorphism. Gut. New Jersey: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 02 nov. 2024. , 2002
APA
Bittencourt, P. L., Palacios, S. A., Cançado, E. L. R., Carrilho, F. J., Porta, G., Kalil Filho, J. E., & Goldberg, A. C. (2002). Susceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1*13 but not with tumour necrosis factor alfa: 308 promoter polymorphism. Gut. New Jersey: Faculdade de Medicina, Universidade de São Paulo.
NLM
Bittencourt PL, Palacios SA, Cançado ELR, Carrilho FJ, Porta G, Kalil Filho JE, Goldberg AC. Susceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1*13 but not with tumour necrosis factor alfa: 308 promoter polymorphism. Gut. 2002 ; 51( 4): 609.[citado 2024 nov. 02 ]
Vancouver
Bittencourt PL, Palacios SA, Cançado ELR, Carrilho FJ, Porta G, Kalil Filho JE, Goldberg AC. Susceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1*13 but not with tumour necrosis factor alfa: 308 promoter polymorphism. Gut. 2002 ; 51( 4): 609.[citado 2024 nov. 02 ]
Artigo de periodico-divulgacao
Suceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1`AST´12 but not with tumour necrosis factor `alpha´-308 promoter polymorphism (2002)
Bittencourt, P. L.; Palacios, S. A.; Cançado, Eduardo Luiz Rachid; Carrilho, Flair José; Porta, G.; Kalil, J.; Goldberg, Anna Carla
Source: Gut. Unidades: FM, IQ
Subjects: HEPATITE, AUTOIMUNIDADE, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITTENCOURT, P. L. et al. Suceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1`AST´12 but not with tumour necrosis factor `alpha´-308 promoter polymorphism. Gut. London: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 02 nov. 2024. , 2002
APA
Bittencourt, P. L., Palacios, S. A., Cançado, E. L. R., Carrilho, F. J., Porta, G., Kalil, J., & Goldberg, A. C. (2002). Suceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1`AST´12 but not with tumour necrosis factor `alpha´-308 promoter polymorphism. Gut. London: Faculdade de Medicina, Universidade de São Paulo.
NLM
Bittencourt PL, Palacios SA, Cançado ELR, Carrilho FJ, Porta G, Kalil J, Goldberg AC. Suceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1`AST´12 but not with tumour necrosis factor `alpha´-308 promoter polymorphism. Gut. 2002 ; 51( 4): 609-610.[citado 2024 nov. 02 ]
Vancouver
Bittencourt PL, Palacios SA, Cançado ELR, Carrilho FJ, Porta G, Kalil J, Goldberg AC. Suceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1`AST´12 but not with tumour necrosis factor `alpha´-308 promoter polymorphism. Gut. 2002 ; 51( 4): 609-610.[citado 2024 nov. 02 ]

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024